aliskiren + atenolol

**Aliskiren + atenolol** is an oral combination of two antihypertensive agents: **aliskiren**, a direct renin inhibitor, and **atenolol**, a beta-1 adrenergic receptor blocker (beta blocker). Aliskiren works by inhibiting the activity of renin, thus reducing the conversion of angiotensinogen to angiotensin I, ultimately lowering blood pressure through suppression of the renin-angiotensin-aldosterone system. Atenolol reduces blood pressure by selectively blocking beta-1 adrenergic receptors, decreasing heart rate and cardiac output. The combination has been studied for enhanced blood pressure lowering, showing greater reductions in systolic and diastolic blood pressure than either agent alone in patients with hypertension. The combination also demonstrates an additive effect on blood pressure control while maintaining a tolerable safety profile[1][2].

Other names

aliskiren and atenololaliskiren plus atenolol